Discovery of a HeliconTM peptide inhibitor of the beta-catenin-TCF interaction with in vivo activity
DOI:
文献链接:
其他信息:
BH White, Y Si, S Cappucci, Z Li, JD Ramirez…
Cancer …, 2023
aacrjournals.org
Wnt signaling pathway mutations leading to constitutive activation of the driver oncogene β-catenin occur in at least 20% of all human cancers, but β-catenin itself has remained undruggable by traditional modalities. In order to inhibit the activity of β-catenin, we have developed conformationally hyperstabilized α-helical peptides (Helicons) that are cellularly permeable and bind directly to β-catenin in order to block its interaction with TCF family of transcription factors. Starting with a helical peptide derived from phage display, a …

